Alx Oncology Holdings (ALXO) Total Current Liabilities (2019 - 2026)

Alx Oncology Holdings' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $20.2 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 7.66% year-over-year to $20.2 million; the TTM figure through Mar 2026 stood at $20.2 million (up 7.66% YoY), while the FY2025 annual figure was $24.6 million, up 32.72% from the prior year.
• Total Current Liabilities came in at $20.2 million for Q1 2026 at Alx Oncology Holdings, down from $24.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $38.4 million in Q2 2024 to a low of $15.3 million in Q1 2022.
• A 5-year average of $25.6 million and a median of $24.6 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities surged 118.81% in 2024 and sank 50.98% in 2025, its largest moves.
• Alx Oncology Holdings' Total Current Liabilities stood at $28.3 million in 2022, then gained by 27.1% to $36.0 million in 2023, then tumbled by 48.61% to $18.5 million in 2024, then jumped by 32.72% to $24.6 million in 2025, then fell by 17.82% to $20.2 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $20.2 million, $24.6 million, and $27.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison